Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-IFN alfa-2a add-on in HBeAg-negative genotype D chronic hepatitis B patients on nucleos(t)ide analogues
2012-000080-25Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Roche. Started Oct 2012; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2012-000080-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000080-25.